These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8941225)

  • 1. Pediatric HIV infection.
    Wiznia AA; Lambert G; Pavlakis S
    Med Clin North Am; 1996 Nov; 80(6):1309-36. PubMed ID: 8941225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for prevention of perinatal transmission of HIV infection. Siena Consensus Workshop II.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):161-75. PubMed ID: 7530586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
    JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: perinatally acquired HIV/AIDS--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1086-92. PubMed ID: 9385878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and medical treatment of the HIV-exposed infant. American Academy of Pediatrics. Committee on Pediatric AIDS.
    Pediatrics; 1997 Jun; 99(6):909-17. PubMed ID: 9190556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
    Wortley PM; Lindegren ML; Fleming PL
    MMWR Recomm Rep; 2001 May; 50(RR-6):17-28. PubMed ID: 15580801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and management of HIV infection.
    Gold JW
    Med Clin North Am; 1996 Nov; 80(6):1283-307. PubMed ID: 8941224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children of the epidemic.
    Vazquez E
    Posit Aware; 1996; 7(5):35-6. PubMed ID: 11363788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(5):93-7. PubMed ID: 11892955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in perinatal transmission of HIV/AIDS in the United States.
    Lindegren ML; Byers RH; Thomas P; Davis SF; Caldwell B; Rogers M; Gwinn M; Ward JW; Fleming PL
    JAMA; 1999 Aug; 282(6):531-8. PubMed ID: 10450714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS among children--United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1005-10. PubMed ID: 8965798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus and AIDS in Uganda.
    Mugerwa RD; Marum LH; Serwadda D
    East Afr Med J; 1996 Jan; 73(1):20-6. PubMed ID: 8625856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstetric and perinatal consequences of human immunodeficiency virus (HIV) infection: a review.
    Peckham CS; Senturia YD; Ades AE
    Br J Obstet Gynaecol; 1987 May; 94(5):403-7. PubMed ID: 3555606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and HIV infection.
    Mehta P; Bentrup KL
    J Fla Med Assoc; 1996; 83(7):473-8. PubMed ID: 8824089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of pediatric human immunodeficiency virus infection in the United States.
    Rogers MF; Caldwell MB; Gwinn ML; Simonds RJ
    Ann N Y Acad Sci; 1993 Oct; 693():4-8. PubMed ID: 8267294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.